Matthias Aizenberg

The painstaking and often inefficient process of manually sifting through thousands of patient records to find eligible candidates for clinical trials has long been a major bottleneck in medical innovation. The use of Artificial Intelligence in patient screening represents a significant advancement

As a Biopharma and technology innovation expert, I've had the privilege of witnessing how artificial intelligence is beginning to revolutionize fields that were once considered the exclusive domain of human intuition. One of the most profoundly moving applications is in pediatric medicine,

A profound paradox exists within modern pharmacology where the treatments designed to combat deadly diseases can simultaneously inflict severe and lasting damage on the human brain. For countless individuals undergoing treatment for conditions like HIV and cancer, this is a harsh reality; up to

The shadow of a dementia diagnosis often looms large, especially for those with a family history, creating a sense of genetic inevitability that can be both frightening and disempowering. However, groundbreaking research from UC San Francisco is challenging this deterministic view, suggesting that

The acidic microenvironment of a solid tumor, once considered a mere byproduct of metabolism, is now being repurposed as a precise trigger for a new generation of cancer-killing vaccines designed to overcome the limitations of conventional immunotherapies. The development of pH-responsive

For decades, the story of how ADHD medications work seemed straightforward: they helped the brain focus. But recent research has completely upended that long-held belief. Today, we're speaking with Ivan Kairatov, a biopharma expert at the forefront of neuroscience and innovation. He’s here to

We are joined by Ivan Kairatov, a biopharma expert whose work sits at the cutting edge of technology and clinical innovation. His latest research venture, Observer, is poised to reshape our understanding of healthcare by moving beyond the static, text-based data of electronic health records. The

The promise of extending human lifespan has captivated scientists for generations, yet the reality of a longer life often comes with a decline in health that modern medicine struggles to prevent. As lifespans increase globally, the gap between how long people live and how long they stay healthy

A foundational pillar of cancer research has received significant reinforcement through a new study that confirms the validity of a key laboratory model for high-grade serous ovarian carcinoma (HGSOC), the most lethal form of ovarian cancer. This disease presents a formidable clinical challenge,

A promising class of anti-cancer drugs, designed with pinpoint precision to kill tumor cells, was abruptly sidelined by a mysterious and life-threatening side effect, leaving a potential breakthrough in oncology on the shelf. This clinical roadblock highlighted a fundamental challenge in modern